Compare Mutual Funds

Pros
5Y returns in the top 25% of the category.

5Y returns in the top 25% of the category.

3Y returns in the top 25% of the category.

3Y returns in the top 25% of the category.

Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

Larger AUM within category.

Larger AUM within category.

Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

Cons

-

5Y returns in the bottom 25% of the category.

5Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

INDMoney rank
1/8
8/8
Category

Equity, Sector - Healthcare

Equity, Sector - Healthcare

Fund Age

13 Years 6 Months

13 Years 6 Months

Fund AUM

₹4323 Cr

₹8365 Cr

Min Investment
  1. SIP ₹500
  2. Lumpsum ₹5000
  1. SIP ₹100
  2. Lumpsum ₹5000
Expense Ratio

0.92%

0.93%

Exit Load

0.5%

1%

Benchmark Index

BSE Healthcare TR INR

BSE Healthcare TR INR

No of Holdings

37

39

Top 5 Holdings
  1. Sun Pharmaceuticals Industries Ltd(12.11%)
  2. Divi's Laboratories Ltd(6.59%)
  3. Acutaas Chemicals Ltd(5.67%)
  4. Apollo Hospitals Enterprise Ltd(5.48%)
  5. Max Healthcare Institute Ltd Ordinary Shares(4.97%)
  1. Sun Pharmaceuticals Industries Ltd(13.92%)
  2. Lupin Ltd(8.45%)
  3. Divi's Laboratories Ltd(6.41%)
  4. Dr Reddy's Laboratories Ltd(5.96%)
  5. Cipla Ltd(5.42%)
No of Sectors

3

1

Top 3 Sectors
  1. Health(90.6%)
  2. Basic Materials(9.4%)
  3. Government(2.08%)

Health

(100%)

Equity %

98.15%

99.46%

Debt %

0.07%

-

P/E

45.58

35.41

P/B

6.49

5.64

Credit Quality

-

-

Modified Duration

-

-

YTM

-

-

1-Month Return

9.18%

6.75%

3-Month Return

9.41%

4.99%

6-Month Return

7.58%

3.49%

1-Year Return

13.15%

10.11%

3-Year Return

27.96%

24.22%

5-Year Return

16.88%

13.89%

Sharpe

1.23

1.01

Alpha

2.96

-0.24

Beta

0.85

0.91

Standard Deviation

14.84

15.78

Information Ratio

0.21

-0.55

Description

SBI Healthcare Opportunities Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Managers

Tanmaya Desai

Sailesh Raj Bhan, Kinjal Desai, Amber Singhania

Most Popular Comparisons